Literature DB >> 32310250

Trends in Utilization of Prescribed Controlled Substances in US Commercially Insured Adults, 2004-2019.

Katsiaryna Bykov1, Mengdong He1, Joshua J Gagne1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32310250      PMCID： PMC7171580          DOI： 10.1001/jamainternmed.2020.0989

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.

Authors:  Gery P Guy; Kun Zhang; Michele K Bohm; Jan Losby; Brian Lewis; Randall Young; Louise B Murphy; Deborah Dowell
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-07-07       Impact factor: 17.586

2.  Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.

Authors:  Lawrence Scholl; Puja Seth; Mbabazi Kariisa; Nana Wilson; Grant Baldwin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-04       Impact factor: 17.586
  3 in total
  4 in total

1.  Trends and variation in benzodiazepine use in nursing homes in the USA.

Authors:  Ioannis Malagaris; Hemalkumar B Mehta; James S Goodwin
Journal:  Eur J Clin Pharmacol       Date:  2021-11-02       Impact factor: 3.064

2.  Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications.

Authors:  Callie G Downs; Tyler J Varisco; Shweta S Bapat; Chan Shen; J Douglas Thornton
Journal:  Res Social Adm Pharm       Date:  2020-06-03

3.  Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors.

Authors:  Ismaeel Yunusa; Joshua J Gagne; Kazuki Yoshida; Katsiaryna Bykov
Journal:  JAMA Netw Open       Date:  2022-02-01

4.  Postoperative inpatient utilization of opioid and opioid-sparing analgesics in the United States hospitals, 2007-2017.

Authors:  Katsiaryna Bykov; Elisabetta Patorno; Jessica M Franklin; Seanna M Vine; Brian T Bateman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2021-01-05       Impact factor: 2.890
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.